Omeprazole Histamine
Omeprazole Histamine - Related Videos
01:28
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
0 Views •
2024
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
08:32
Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
0 Views •
Cited by 21 •
2017
This manuscript presents protocols for the application of novel genetically encoded nitric oxide (NO•) probes (geNOps) to monitor single cell NO• fluctuations in real-time using fluorescence microscopy. The Ca2+-triggered NO• formation on the level of individual endothelial cells was visualized by combining geNOps with a chemical Ca2+ sensor.
03:20
Evaluating Pneumococcal Attachment to Primary Human Endothelial Cells Under Constant Media Flow
0 Views •
2025
Source: Jagau, H. et al. Pneumococcus Infection of Primary Human Endothelial Cells in Constant Flow. J. Vis. Exp. (2019)This video demonstrates the real-time visualization of pneumococcal attachment to Von Willebrand Factor (VWF) strings on endothelial cells under constant media flow conditions. It outlines the steps for stimulating VWF release, labeling the strings, and quantifying bacterial binding.
09:33
An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
0 Views •
Cited by 3 •
2016
A low-cost, easy-to-use and powerful system is established to evaluate potential treatments that could ameliorate blood retinal barrier breach induced by histamine. Blood vessel leakage, Müller cell activation and the continuity of neuronal processes are utilized to assess the damage response and its reversal with a potential drug, lipoxin A4.
12:52
Iridium(III) Luminescent Probe for Detection of the Malarial Protein Biomarker Histidine Rich Protein-II
0 Views •
Cited by 4 •
2015
Robust detection reagents are of increasing necessity for developing new malaria diagnostic tools. An iridium(III) probe was designed that emits long-lasting luminescent signal in the presence of a histidine-rich malarial protein biomarker. Detection of the protein either in solution or immobilized on a magnetic particle affords flexibility in application.
FAQs
Histamine acts upstream by binding H2 receptors on gastric parietal cells and increasing intracellular cAMP. That signal activates the H+/K+-ATPase, the proton-secretion machinery responsible for acid release. Omeprazole acts farther downstream, so it can suppress secretion even when histamine has already initiated receptor signaling. This separation helps distinguish receptor activation from final acid-production steps.
Acidic secretory canaliculi convert omeprazole into its active form, positioning activation near the proton-secretion machinery. The activated drug then irreversibly inhibits the H+/K+-ATPase. This mechanism links the drug’s activity to the acid-secreting environment and explains why its effect targets the final stage of secretion rather than preventing histamine from binding its receptor.
The H+/K+-ATPase represents a final common step through which histamine-driven stimulation produces gastric acid secretion. Blocking this step can reduce acid output without requiring interruption of the earlier H2-receptor and cAMP events. In pharmacology, that distinction allows investigators to separate preserved receptor signaling from suppressed physiological secretion.
Studying histamine alone emphasizes H2-receptor activation, cAMP formation, and stimulation of the parietal cell. Adding omeprazole introduces an intervention at the terminal proton-secretion step. Comparing these conditions can show whether a change in acid output reflects altered receptor signaling or inhibition of the downstream H+/K+-ATPase, improving interpretation of gastric physiology experiments.
A pharmacology study can use histamine-driven stimulation as a defined challenge and then examine acid secretion with omeprazole present. The comparison tests whether the drug suppresses the physiological response despite continued upstream stimulation. Such an approach connects drug exposure with functional acid reduction and supports evaluation of therapeutic efficacy within the gastric secretory pathway.
Because omeprazole inhibits the terminal machinery for proton secretion, its effects can be interpreted in terms of overall gastric acid reduction rather than only receptor-level changes. This is relevant to acid-related disorders and to studies of gastric physiology, where investigators may examine how blocking the pump changes secretion after histamine or other secretagogues stimulate parietal cells.